Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Invested Capital: 2019-2021

  • Bright Minds Biosciences' Invested Capital was N/A to $22.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was $22.0 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2020, which is 13.07% up from last year.
  • Per Bright Minds Biosciences' latest filing, its Invested Capital stood at $22.0 million for Q2 2021, which was up 2.24% from $21.5 million recorded in Q1 2021.
  • In the past 5 years, Bright Minds Biosciences' Invested Capital registered a high of $22.0 million during Q2 2021, and its lowest value of $3.1 million during Q3 2019.
  • Moreover, its 3-year median value for Invested Capital was $4.9 million (2020), whereas its average is $11.0 million.
  • Data for Bright Minds Biosciences' Invested Capital shows a peak YoY rose of 14.05% (in 2020) over the last 5 years.
  • Quarterly analysis of 3 years shows Bright Minds Biosciences' Invested Capital stood at $3.1 million in 2019, then grew by 14.05% to $4.9 million in 2020, then reached $22.0 million in 2021.
  • Its Invested Capital stands at $22.0 million for Q2 2021, versus $21.5 million for Q1 2021 and $4.9 million for Q4 2020.